BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mieog JSD, Achterberg FB, Zlitni A, Hutteman M, Burggraaf J, Swijnenburg RJ, Gioux S, Vahrmeijer AL. Fundamentals and developments in fluorescence-guided cancer surgery. Nat Rev Clin Oncol 2021. [PMID: 34493858 DOI: 10.1038/s41571-021-00548-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan X, Xia Q, Liu S, Zheng Z, Zhang Y, Wu T, Li Y, Tang G, Tang BZ, Qian J, Lin H. NIR-II and visible fluorescence hybrid imaging-guided surgery via aggregation-induced emission fluorophores cocktails. Mater Today Bio 2022;16:100399. [PMID: 36052153 DOI: 10.1016/j.mtbio.2022.100399] [Reference Citation Analysis]
2 Cheng Z, Ma J, Yin L, Yu L, Yuan Z, Zhang B, Tian J, Du Y. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications. Eur J Nucl Med Mol Imaging 2022. [DOI: 10.1007/s00259-022-06056-5] [Reference Citation Analysis]
3 Shmuylovich L, O'brien C, Nwosu K, Achilefu S. Global health open-source goggles for fluorescence-guided surgery.. [DOI: 10.21203/rs.3.rs-2222595/v1] [Reference Citation Analysis]
4 Liu J, Xiong Y, Gao Y, Xu X, Chen K, Shen Q, Huang W, Fan Q, Wang Q. Molecular Oligomerization and Donor Engineering Strategies for Achieving Superior NIR‐II Fluorescence Imaging and Thermotherapy under 1064 nm Laser Irradiation. Small 2022. [DOI: 10.1002/smll.202205640] [Reference Citation Analysis]
5 Ségaud S, Baratelli L, Felli E, Bannone E, Cinelli L, Rodríguez-luna MR, Okamoto N, Keller DS, de Mathelin M, Lecler S, Diana M, Gioux S. Trident: A dual oxygenation and fluorescence imaging platform for real-time and quantitative surgical guidance. Front Photon 2022;3. [DOI: 10.3389/fphot.2022.1032776] [Reference Citation Analysis]
6 Exner RM, Cortezon-tamarit F, Ge H, Pourzand C, Pascu SI. Unraveling the Chemistry of meso-Cl Tricarbocyanine Dyes in Conjugation Reactions for the Creation of Peptide Bonds. ACS Bio Med Chem Au 2022. [DOI: 10.1021/acsbiomedchemau.2c00053] [Reference Citation Analysis]
7 Larochelle EPM, Streeter SS, Littler EA, Ruiz AJ. 3D-Printed Tumor Phantoms for Assessment of In Vivo Fluorescence Imaging Analysis Methods. Mol Imaging Biol 2022. [DOI: 10.1007/s11307-022-01783-5] [Reference Citation Analysis]
8 Zhang L, Li W, Parvin R, Wang X, Fan Q, Ye F. Screening Prostate Cancer Cell‐Derived Exosomal MicroRNA Expression with Photothermal‐Driven Digital PCR. Adv Funct Materials. [DOI: 10.1002/adfm.202207879] [Reference Citation Analysis]
9 Ćwilichowska N, Świderska KW, Dobrzyń A, Drąg M, Poręba M. Diagnostic and therapeutic potential of protease inhibition. Mol Aspects Med 2022;88:101144. [PMID: 36174281 DOI: 10.1016/j.mam.2022.101144] [Reference Citation Analysis]
10 Van Keulen S, Hom M, White H, Rosenthal EL, Baik FM. The Evolution of Fluorescence-Guided Surgery. Mol Imaging Biol 2022. [PMID: 36123445 DOI: 10.1007/s11307-022-01772-8] [Reference Citation Analysis]
11 Martin E, Hom M, Mani L, Rosenthal EL. Current and Future Applications of Fluorescence-Guided Surgery in Head and Neck Cancer. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2022.07.001] [Reference Citation Analysis]
12 Zhang Z, Fang C, Zhang Y, Su S, Li B, Liu G, Hu Z, Tian J. NIR-II nano fluorescence image guided hepatic carcinoma resection on cirrhotic patient. Photodiagnosis Photodyn Ther 2022;:103098. [PMID: 36055624 DOI: 10.1016/j.pdpdt.2022.103098] [Reference Citation Analysis]
13 Wongso H. Recent progress on the development of fluorescent probes targeting the translocator protein 18 kDa (TSPO). Anal Biochem 2022;655:114854. [PMID: 35963341 DOI: 10.1016/j.ab.2022.114854] [Reference Citation Analysis]
14 Hou Y, Fei Y, Liu Z, Liu Y, Li M, Luo Z. Black phosphorous nanomaterials as a new paradigm for postoperative tumor treatment regimens. J Nanobiotechnology 2022;20:366. [PMID: 35953821 DOI: 10.1186/s12951-022-01579-3] [Reference Citation Analysis]
15 De Ravin E, Venkatesh S, Harmsen S, Delikatny EJ, Husson MA, Lee JYK, Newman JG, Rajasekaran K. Indocyanine green fluorescence-guided surgery in head and neck cancer: A systematic review. Am J Otolaryngol 2022;43:103570. [PMID: 35939987 DOI: 10.1016/j.amjoto.2022.103570] [Reference Citation Analysis]
16 Wu L, Zhao Q, Wang Q, Zhang Q, Yang F, Zheng B, Hu H, Xing N. Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.018] [Reference Citation Analysis]
17 Dai J, Xue H, Chen D, Lou X, Xia F, Wang S. Aggregation-induced emission luminogens for assisted cancer surgery. Coordination Chemistry Reviews 2022;464:214552. [DOI: 10.1016/j.ccr.2022.214552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
18 Nishio N, Mitani S, Sakamoto K, Morimoto G, Yokoi S, Shigeyama M, Wada A, Mukoyama N, Rosenthal EL, Sone M. Validation of a surgical training model containing indocyanine green for near‐infrared fluorescence imaging. Laryngoscope Investig Oto. [DOI: 10.1002/lio2.858] [Reference Citation Analysis]
19 Song S, Wang Y, Zhao Y, Huang W, Zhang F, Zhu S, Wu Q, Fu S, Tang BZ, Wang D. Molecular engineering of AIE luminogens for NIR-II/IIb bioimaging and surgical navigation of lymph nodes. Matter 2022. [DOI: 10.1016/j.matt.2022.06.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Wei X, Zhang C, He S, Huang J, Huang J, Liew SS, Zeng Z, Pu K. A Dual-Locked Activatable Phototheranostic Probe for Biomarker-Regulated Photodynamic and Photothermal Cancer Therapy. Angew Chem Int Ed Engl 2022;61:e202202966. [PMID: 35396786 DOI: 10.1002/anie.202202966] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
21 Ueo H, Minoura I, Ueo H, Gamachi A, Kai Y, Kubota Y, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Urano Y, Mori M, Mimori K. Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements. Sci Rep 2022;12:8520. [PMID: 35595810 DOI: 10.1038/s41598-022-12614-6] [Reference Citation Analysis]
22 Josserand V, Bernard C, Michy T, Guidetti M, Vollaire J, Coll J, Hurbin A. Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis. Biomedicines 2022;10:1059. [DOI: 10.3390/biomedicines10051059] [Reference Citation Analysis]
23 Netufo O, Connor K, Shiels LP, Sweeney KJ, Wu D, O’shea DF, Byrne AT, Miller IS. Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents. Pharmaceuticals 2022;15:550. [DOI: 10.3390/ph15050550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Neijenhuis LKA, de Myunck LDAN, Bijlstra OD, Kuppen PJK, Hilling DE, Borm FJ, Cohen D, Mieog JSD, Steup WH, Braun J, Burggraaf J, Vahrmeijer AL, Hutteman M. Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic Review. Life 2022;12:446. [DOI: 10.3390/life12030446] [Reference Citation Analysis]
25 Barth CW, Gibbs SL. The advantages and disadvantages of novel contrast agent types for fluorescence guided surgery. Molecular-Guided Surgery: Molecules, Devices, and Applications VIII 2022. [DOI: 10.1117/12.2613182] [Reference Citation Analysis]
26 Kinami S, Saito H, Takamura H. Significance of Lymph Node Metastasis in the Treatment of Gastric Cancer and Current Challenges in Determining the Extent of Metastasis. Front Oncol 2021;11:806162. [PMID: 35071010 DOI: 10.3389/fonc.2021.806162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Feng Z, Li Y, Chen S, Yu X, Ying Y, Zheng J, Wu T, Li J, Fan X, Zhang D, Qian J. Fluorescence visualization of deep-buried hollow organs.. [DOI: 10.1101/2022.01.07.475462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 van Dam MA, Vuijk FA, Stibbe JA, Houvast RD, Luelmo SAC, Crobach S, Shahbazi Feshtali S, de Geus-Oei LF, Bonsing BA, Sier CFM, Kuppen PJK, Swijnenburg RJ, Windhorst AD, Burggraaf J, Vahrmeijer AL, Mieog JSD. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers (Basel) 2021;13:6088. [PMID: 34885196 DOI: 10.3390/cancers13236088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Turner MA, Lwin TM, Amirfakhri S, Nishino H, Hoffman RM, Yazaki PJ, Bouvet M. The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review. Biomolecules 2021;11:1819. [PMID: 34944463 DOI: 10.3390/biom11121819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]